The IAEA’s expertise in medical physics and dosimetry is enhancing the capacities of countries around the globe to use ionizing radiation in medical procedures safely and effectively, the Scientific Committee of the IAEA and the World Health Organization (WHO) Network of Secondary Standards Dosimetry Laboratories (SSDLs) heard last month.
Held at IAEA Headquarters in Vienna from 11 to 15 March, the Committee’s 21st biennial meeting evaluated the IAEA’s dosimetry and medical physics efforts in 2022 and 2023; discussed activities for 2024 and 2025; and provided recommendations for 2026 and 2027. The IAEA spotlighted its work on calibrations, auditing, radiation dosimetry and clinical medical radiation physics. Staff presented accomplishments from the previous biennium; planned activities for the current one; and ideas for the next. They also highlighted cross-sectional, collaborative activities as they addressed the committee’s questions on IAEA technical outputs – be it on publications, education and training activities, coordinated research projects (CRP) or data, to name but a few.
“Overall, there has been a fantastic, continued achievement”, Jan Seuntjens – the Committee’s Chair – reflected. “The impact of this is often understated. Initiatives like Rays of Hope cannot be successful without medical physics and the infrastructure that has been set up around the world by the IAEA.”
The Committee – which consists of seven internationally renowned experts in the field – meets every two years to assess the IAEA’s work and provide independent, external advice. First established in 1986 to review the activities of the IAEA’s Dosimetry Laboratory (DOL), the Committee expanded its scope in 1988 to include all IAEA dosimetry and medical physics activities. Its recommendations are not only shared with the Directors General of the IAEA and WHO but also used to inform programme planning.